Key result
2-APB and DPBA reversibly suppressed the input conductance of in situ vascular smooth muscle cells with an IC50 of 4-8 µM and inhibited the delayed rectifier K+ current with an IC50 of ~120 µM.
Effect estimate: IC50 4-8 µM for Ginput; IC50 ~120 µM for IK
2-APB and its analog DPBA are potent and reversible vascular gap junction blockers with a weak side effect of voltage-gated K+ channel inhibition.
2-Aminoethoxydiphenyl borate (2-APB) analogs are potentially better vascular gap junction blockers than others widely used, but they remain to be characterized. Using whole cell and intracellular recording techniques, we studied the actions of 2-APB and its potent analog diphenylborinic anhydride (DPBA) on vascular smooth muscle cells (VSMCs) and endothelial cells in situ of or dissociated from arteriolar segments of the cochlear spiral modiolar artery, brain artery, and mesenteric artery. We found that both 2-APB and DPBA reversibly suppressed the input conductance (G(input)) of in situ VSMCs (IC(50) ≈ 4-8 μM). Complete electrical isolation of the recorded VSMC was achieved at 100 μM. A similar gap junction blockade was observed in endothelial cell tubules of the spiral modiolar artery. Similar to the action of 18β-glycyrrhetinic acid (18β-GA), 2-APB and DPBA depolarized VSMCs. In dissociated VSMCs, 2-APB and DPBA inhibited the delayed rectifier K(+) current (I(K)) with an IC(50) of ∼120 μM in the three vessels but with no significant effect on G(input) or the current-voltage relation between -140 and -40 mV. 2-APB inhibition of I(K) was more pronounced at potentials of ≤20 mV than at +40 mV and more marked on the fast component than on the slow component, which was mimicked by 4-aminopyridine but not by tetraethylammonium, nitrendipine, or charybdotoxin. In contrast, 18β-GA caused a linear inhibition of I(K) between 0 to +40 mV, which was similar to the action of tetraethylammonium or charybdotoxin. Finally, the 2-APB-induced inhibition of electrical coupling and I(K) was not affected by the inositol 1,4,5-trisphosphate receptor antagonist xestospongin C. We conclude that 2-APB analogs are a class of potent and reversible vascular gap junction blockers with a weak side effect of voltage-gated K(+) channel inhibition. They could be gap junction blockers superior to 18β-GA only when Ca(2+)-actived K(+) channel inhibition by the latter is a concern but inositol 1,4,5-trisphosphate receptor and voltage-gated K(+) channel inhibitions are not.
No takes yet. Share an insight, caveat, or question.
Ma et al. (2010) studied Normal physiology (guinea pig arterioles) (n=70). 2-Aminoethoxydiphenyl borate (2-APB) and diphenylborinic anhydride (DPBA) vs. Baseline/vehicle and 18β-glycyrrhetinic acid was evaluated on Input conductance (Ginput) and delayed rectifier K+ current (IK) (IC50 4-8 µM for Ginput; IC50 ~120 µM for IK). 2-APB and DPBA reversibly suppressed the input conductance of in situ vascular smooth muscle cells with an IC50 of 4-8 µM and inhibited the delayed rectifier K+ current with an IC50 of ~120 µM.
Synapse has enriched 5 closely related papers on similar clinical questions. Consider them for comparative context: